- Author:
Concetta CRISAFULLI
1
;
Marco CALABRÒ
;
Laura MANDELLI
;
Sheng-Min WANG
;
Soo-Jung LEE
;
Changsu HAN
;
Ashwin PATKAR
;
Prakash MASAND
;
Chi-Un PAE
;
Daniel SOUERY
;
Julien MENDLEWICZ
;
Alessandro SERRETTI
Author Information
- Publication Type:Original Article
- From:Clinical Psychopharmacology and Neuroscience 2021;19(1):46-52
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:The genetic background of mood disorders is gradually emerging through the use of large multicenter samples but a detailed phenotyping is complementary in elucidating the role of modulating variants.
Methods:In the present paper we focused on the possible modulatory effects of ARC gene variants on two independent mood disorder samples of European (n = 246 bipolar disorder) and Korean (n = 132 bipolar disorder; n = 242 major depressive disorder [MDD]) ancestry.
Results:No result survived Bonferroni correction, however we evidenced promising trend toward possible association between ARC gene variants and mood disorder phenotypes. In particular, we evidenced weak correlations of ARC single nucleotide polymorphisms with depressive symptoms severity (evaluated through Hamilton depression rating scale scores) in the MDD Korean (rs7465272) and European (rs11167152) samples. Additionally rs10110456 was found to be related to Family History, while rs7465272 was related to suicide risk in the Korean sample. Finally, rs7465272 was associated with body mass index in the European sample.
Conclusion:Overall, ARC gene variants may have a partial role in modulatory effect on treatment efficacy or phenotypes of mood disorders. Further studies, on larger samples may provide a better understanding on the role of ARC gene variants in the symptom severity and treatment outcomes in patients with mood disorders.